Grabar Law Office investigates fiduciary breach claims against Commvault, LKQ, Phreesia, and Power Solutions International

Regulation
โดย GlobeNewswire·Read original
Summary · why it matters

Grabar Law Office is investigating claims on behalf of long-term shareholders of Commvault Systems, LKQ Corporation, Phreesia, and Power Solutions International, alleging that certain officers and directors breached their fiduciary duties. For Commvault, the investigation concerns allegedly misleading guidance on annual recurring revenue growth for fiscal year 2026, with shareholders who purchased before April 29, 2025 and still hold shares encouraged to seek corporate reforms. The LKQ probe relates to a securities fraud class action alleging that senior executives misled investors about the performance and risks of the $2.1 billion acquisition of Uni-Select, including the FinishMaster business, with shareholders who held shares since before February 27, 2023 eligible to participate. Phreesia's investigation follows a complaint claiming the company made false statements about slowing demand and weakened pharmaceutical marketing commitments in its Network Solutions segment, affecting shareholders who purchased before May 8, 2025. Power Solutions International is also under investigation after a class action alleged the company overstated its ability to capture data center market demand and understated the costs of manufacturing capacity enhancements, with shareholders who acquired securities before May 8, 2025 able to seek reforms.

Impact on stocks 5

Cybersecurity & Digital Trust▼ · 1 stocks
CommVault Systems Inc
CVLT
▼ NegativeRegulationrelevance

Investigation into allegedly misleading guidance on annual recurring revenue growth for FY2026.

Consumer Discretionary▼ · 1 stocks
LKQ Corporation
LKQ
▼ NegativeRegulationrelevance

Securities fraud class action alleging misleading statements about Uni-Select acquisition performance.

Cloud & Digital Infrastructure▼ · 1 stocks
Phreesia Inc
PHR
▼ NegativeRegulationrelevance

Investigation into false statements about slowing demand and weakened pharmaceutical marketing commitments.

Energy Transition & Power Demand▼ · 1 stocks
Artificial Intelligence▲ · 1 stocks
© 2026 MarketDXNews